Form 4 Tracker
Henry E. Pelish

Chief Scientific Officer · 2 filings · Latest: Apr 9, 2026

Nuvalent, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
NUVL
Henry E. PelishChief Scientific OfficerApr 9, 2026
Sale
$104.483,093$323.2K65,604
NUVL
Henry E. PelishChief Scientific OfficerApr 9, 2026
Option Exercise
$27.853,093$86.1K68,697
NUVL
Henry E. PelishChief Scientific OfficerMar 13, 2026
Sale
$98.985,104$505.2K65,604
NUVL
Henry E. PelishChief Scientific OfficerMar 12, 2026
Sale
$97.9230,000$2.9M70,708
NUVL
Henry E. PelishChief Scientific OfficerMar 12, 2026
Option Exercise
$31.5217,320$545.9K100,708
NUVL
HENRY E PELISHMar 12, 2026
Proposed Sale
$100.0538,197$3.8M
NUVL
Henry E. PelishJan 6, 2026
Proposed Sale
$97.645,160$503.8K
NUVL
HENRY E PELISHOct 13, 2025
Proposed Sale
$88.1021,842$1.9M
NUVL
HENRY E PELISHSep 10, 2025
Proposed Sale
$78.736,158$484.8K
NUVL
Henry E. PelishJul 9, 2025
Proposed Sale
$81.152,145$174.1K
NUVL
HENRY E PELISHJun 6, 2025
Proposed Sale
$78.0922,000$1.7M
NUVL
Henry E. PelishJan 6, 2025
Proposed Sale
$80.782,750$222.1K
NUVL
Henry PelishAug 23, 2024
Proposed Sale
$84.1343,295$3.6M